Pentax

Waycen and MegaMind Sign AI Endoscopy supply Agreement to Medical market in the Middle East

Retrieved on: 
Monday, February 19, 2024

Through this agreement, Waycen will leverage MegaMind IT Solution's extensive network in the Middle East healthcare market to introduce its artificial intelligence gastrointestinal endoscopy software 'WAYMED Endo' and AI respiratory self-screening service 'WAYMED Cough.'

Key Points: 
  • Through this agreement, Waycen will leverage MegaMind IT Solution's extensive network in the Middle East healthcare market to introduce its artificial intelligence gastrointestinal endoscopy software 'WAYMED Endo' and AI respiratory self-screening service 'WAYMED Cough.'
  • This collaboration aims to solidify Waycen's presence in the Middle East medical market.
  • MegaMind, IT Solution a specialized company located in Saudi Arabia, owns 13 group hospitals within the Middle East region.
  • Hamza Batterjee, the CEO of MegaMind, expressed his confidence in the agreement, saying, " MegaMind has a mission and confidence to lead digital innovation in the Middle East healthcare market."

Motus GI Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Monday, August 14, 2023

The Company incurred non-recurring charges related to these cost-cutting measures of approximately $1.5 million in the first half of 2023.

Key Points: 
  • The Company incurred non-recurring charges related to these cost-cutting measures of approximately $1.5 million in the first half of 2023.
  • Financial Results for the Second Quarter Ended June 30, 2023
    The Company reported revenue of $113,000 for the second quarter 2023, compared to $185,000 for the same period last year.
  • The Company reported $8.5 million in cash and cash equivalents as of June 30, 2023.
  • The Company believes that its cash and cash equivalents as of June 30, 2023 will be sufficient to allow the Company to fund its commercial, R&D and corporate operations through the first quarter of 2024.

Motus GI Announces Pure-Vu Gen 4 Gastro and Colon System Featured at 9th IECED Live Endoscopy Course 2023 at the Pentax Learning Center

Retrieved on: 
Wednesday, June 14, 2023

The Pure-Vu Gen 4 system will have a new mode called “fluid only” that the user can select when needed to support this new use case of UEMR.

Key Points: 
  • The Pure-Vu Gen 4 system will have a new mode called “fluid only” that the user can select when needed to support this new use case of UEMR.
  • “We are pleased by the positive feedback our Pure-Vu Gen 4 system received from physicians participating in the IECED course 2023,” commented Mark Pomeranz, Chief Executive Officer.
  • “We believe the advanced capabilities of this important next generation of our technology is continuing to generate broad interest in the Pure-Vu system.
  • The Company is also leveraging this Gen 4 technology to enhance the Pure-Vu device in the colon.

Motus GI Completes First Clinical Evaluation of New Pure-Vu® Gastro in Upper Gastrointestinal (GI) Procedures to Support FDA Submission

Retrieved on: 
Wednesday, May 17, 2023

FORT LAUDERDALE, Fla., May 17, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, today announced in collaboration with the Ecuadorian Institute of Digestive Diseases (IECED) initiation of a clinical evaluation of the Pure-Vu Gen 4 Gastro, which is designed for upper gastrointestinal (GI) bleeding procedures - an area of high unmet patient need.

Key Points: 
  • “We are excited to initiate this important clinical evaluation of the Pure-Vu Gen 4 Gastro with Dr. Carlos Robles-Medranda and the team at IECED.
  • The focus of these procedures was aimed at evaluating the device’s ability to improve a physician’s visualization while identifying and treating upper GI bleeds.
  • Dr. Robles-Medranda has already successfully conducted his first series of procedures utilizing the Pure-Vu Gen 4 Gastro and provided positive initial feedback on the device’s performance.
  • The procedures in the upper GI tract were efficient for these first time users with the upper procedures averaging only 11 minutes.

Film Camera Store Release the Top Film Cameras of 2023 That Are Suitable for Both Amateurs and Professionals

Retrieved on: 
Monday, March 13, 2023

With a wide range of new and used 35mm film cameras and accessories, like Contax, Yashica, Leica, Olympus, Pentax, Canon, and Nikon, Film Camera Store has now released the top film cameras of 2023 that are suitable for both amateurs and professionals.

Key Points: 
  • With a wide range of new and used 35mm film cameras and accessories, like Contax, Yashica, Leica, Olympus, Pentax, Canon, and Nikon, Film Camera Store has now released the top film cameras of 2023 that are suitable for both amateurs and professionals.
  • A spokesperson for Camera Film Store says, “Photography may be overwhelmingly digital these days, but the influence of film photography remains.
  • Film Camera Store’s Film Photography Starter Pack has been custom designed for anyone looking to get into film photography.
  • To find out more about Film Camera Store and to see its complete range of new and used film cameras and accessories, please visit the website at https://filmcamerastore.co.uk/ .

The Impacts of Nasotracheal Intubation on Postoperative Sore Throat

Retrieved on: 
Friday, October 14, 2022

LAWRENCE, Kan., Oct. 14, 2022  /PRNewswire-PRWeb/ -- Anesthesia Progress – Stress and anxiety often accompany oral and maxillofacial surgery, but the common side effect of a postoperative sore throat from intubation increases patient complications. The intubation process can occur via direct laryngoscopy, video laryngoscopy, or nasotracheal intubation procedures. Each intubation type has risk factors, but the common occurrence of a resulting sore throat has not been widely reviewed during nasotracheal intubation.

Key Points: 
  • Each intubation type has risk factors, but the common occurrence of a resulting sore throat has not been widely reviewed during nasotracheal intubation.
  • To determine the highest risk factors for postoperative sore throat in nasotracheal intubation, researchers from the Kyushu University Hospital and Kyushu University, Fukuoka, Japan, recently published a retrospective study in the current issue of Anesthesia Progress.
  • Results of this retrospective analysis showed that postoperative sore throat occurred in 74.6% of patients who underwent nasotracheal intubation for oral or maxillofacial surgery.
  • Full text of the article, "Risk Factors for Postoperative Sore Throat After Nasotracheal Intubation," Anesthesia Progress, Vol.

Ricoh announces HD PENTAX-DA★ 16-50mm F2.8ED PLM AW for K-mount digital SLR cameras

Retrieved on: 
Wednesday, July 14, 2021

Designed for use with PENTAX K-mount digital SLR cameras, Star-series lenses boast the highest imaging performance of all PENTAX lens lineups.

Key Points: 
  • Designed for use with PENTAX K-mount digital SLR cameras, Star-series lenses boast the highest imaging performance of all PENTAX lens lineups.
  • The HD PENTAX-DA16-50mm F2.8ED PLM AW lens also features an electromagnetic diaphragm control mechanism to assure high precision exposure control and smooth focus tracking when used in combination with compatible digital SLR cameras.
  • Ricoh Imaging Americas Corporation is a subsidiary of Ricoh Company, Ltd. Ricoh is empowering digital workplaces using innovative technologies and services enabling individuals to work smarter.
  • Ricoh's offering of stylish and compact digital cameras are known for their wide-ranging, unique set of features.

PENTAX Medical Europe to launch single-use bronchoscope

Retrieved on: 
Wednesday, May 26, 2021

TOKYO, May 26, 2021 /PRNewswire/ --PENTAX Medical Europe, a leading company in the endoscopic field, has obtained a CE mark for its new single-use bronchoscope the PulmoONE.

Key Points: 
  • TOKYO, May 26, 2021 /PRNewswire/ --PENTAX Medical Europe, a leading company in the endoscopic field, has obtained a CE mark for its new single-use bronchoscope the PulmoONE.
  • Wolfgang Mayer, Head of Research and Development at PENTAX Medical EMEA, comments: "The single-use bronchoscope was developed in close collaboration with physicians to offer them a solution based on their needs.
  • It is expected the new single-use bronchoscope will be available for clinical use on August 1st, 2021, with full commercial launch to be announced at a later date.
  • Rainer Burkard, Chief Executive Officer PENTAX Medical EMEA and Commercial Officer AMERICAS, continues: "At PENTAX Medical we are committed to addressing the medical device hygiene challenges by continually innovating products, optimizing processes, and integrating feedback from the market.

PENTAX Medical Europe to launch single-use bronchoscope

Retrieved on: 
Wednesday, May 26, 2021

Wolfgang Mayer, Head of Research and Development at PENTAX Medical EMEA, comments: "The single-use bronchoscope was developed in close collaboration with physicians to offer them a solution based on their needs.

Key Points: 
  • Wolfgang Mayer, Head of Research and Development at PENTAX Medical EMEA, comments: "The single-use bronchoscope was developed in close collaboration with physicians to offer them a solution based on their needs.
  • It is expected the new single-use bronchoscope will be available for clinical use on August 1st, 2021, with full commercial launch to be announced at a later date.
  • Rainer Burkard, Chief Executive Officer PENTAX Medical EMEA and Commercial Officer AMERICAS, continues: "At PENTAX Medical we are committed to addressing the medical device hygiene challenges by continually innovating products, optimizing processes, and integrating feedback from the market.
  • We are proud our portfolio now includes a single-use bronchoscope to enhance infection prevention without compromising on high quality pulmonary care."

PENTAX Medical Announces Appointment Of Ojas A. Buch As New President For The Americas

Retrieved on: 
Tuesday, May 4, 2021

Leadership roles at GE Healthcare, St. Jude Medical (Abbott), CareFusion (Yvaire) and most recently Philips have provided Mr. Buch with a keen understanding of the industry and its key players.

Key Points: 
  • Leadership roles at GE Healthcare, St. Jude Medical (Abbott), CareFusion (Yvaire) and most recently Philips have provided Mr. Buch with a keen understanding of the industry and its key players.
  • We firmly believe his strong leadership experience will accelerate product launches and deepen customer engagement in the coming years.
  • "\n"I am proud to serve PENTAX Medical alongside a dedicated team in the Americas.
  • It is through collaboration and innovation that PENTAX Medical anticipates and solves the challenges of our clients," stated Ojas A. Buch.